CRVLCorVel Corporation
Is the price fair?
In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In its normal range: P/E 37.3 vs a 38.0 median over 41 quarters (−2% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What CRVL's price assumes
CorVel Corporation trades at 37.3× earnings against 30.5× for the median Insurance Brokers name, more expensive than its own group.
Trailing P/E · Insurance Brokers median 30.5 · 1.22× the median: the market pays up for this one
- Price / sales
- 3.23
Price / sales · as of 2026-Q2
- Price / book
- 7.78
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 7.78
- Financial Services median P/E599 names
- 12.5
- Insurance Brokers median P/E15 names
- 30.5
- Market capitalisation50.5 million shares, counted Aug 3, 2026
- $4.24B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $64.82 |
| Its own P/E history, median | $85.43 |
| Its own P/E history, upper quartile | $109.67 |
| 52-week range | $46.00 – $83.87 |
| Today | $83.87 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.